The effect of "Parenabol" on patients with osteoporosis.
D015065:17-Hydroxycorticosteroids / Q000008:administration & dosage*; D000368:Aged; D045930:Anabolic Agents / Q000008:administration & dosage*; D000731:Androstanes / Q000008:administration & dosage; D001219:Aspartate Aminotransferases / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002118:Calcium / Q000652:urine; D005260:Female; D006177:Gynecomastia / Q000139:chemically induced; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D007273:Injections, Intramuscular; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy*; D013448:Sulfobromophthalein / Q000652:urine; D014476:Undecylenic Acids / Q000008:administration & dosage
D015065:17-Hydroxycorticosteroids; D045930:Anabolic Agents; D000731:Androstanes; D001798:Blood Proteins; D014476:Undecylenic Acids; D013448:Sulfobromophthalein; D001219:Aspartate Aminotransferases; D002118:Calcium